Table 3.
Trans-18:2 intake | Trans-18:1 intake | |||
---|---|---|---|---|
Multivariate-adjusted difference (95%CI) in each HRV index for each 1 SD (0.06 g/d) higher consumption of trans-18:2 fatty acids* | p | Multivariate-adjusted difference (95%CI) in each HRV index for each 1 SD (0.68 g/d) higher consumption of trans18:1 fatty acids * | p | |
24-hour Heart Rate, bpm† (N=1,076) | +3.20 (0.92, 5.48) | 0.006 | −2.85 (−5.17, −0.52) | 0.02 |
Resting Heart Rate, bpm† (N=1,076) | +3.26 (0.68, 5.83) | 0.01 | −3.09 (−5.71, −0.46) | 0.02 |
| ||||
Time-domain HRV (N=1,076) | ||||
SDNN, ms | −12% (−19, −6) | 0.001 | +16% (7, 25) | <0.001 |
SDANN, ms | −12% (−19, −5) | 0.001 | +16% (7, 26) | <0.001 |
SDNNindex, ms | −11% (−19, −3) | 0.007 | +14% (4, 24) | 0.004 |
rMSSD, ms‡ | −9% (−19, 4) | 0.17 | +7% (−4, 21) | 0.27 |
Frequency-domain HRV (N=1034) | ||||
TP, ms2 | −24% (−36, −11) | 0.001 | +37% (16, 60) | <0.001 |
ULF, ms2 | −24% (−36, −11) | 0.001 | +37% (16, 61) | <0.001 |
VLF, ms2 | −24% (−36, −9) | 0.003 | +33% (11, 60) | 0.002 |
LF/HF, ratio | −1% (−14, 15) | 0.96 | +1% (−13, 17) | 0.90 |
LFnu, % †‡ | +1.09 (−1.04, 3.24) | 0.32 | −0.4 (−2.56, 1.79) | 0.73 |
HFnu, %†‡ | −1.16 (−2.81, 0.5) | 0.17 | +0.65 (−1.03, 2.33) | 0.45 |
Non-linear HRV (N=1034) | ||||
DFA1† | −0.01 (−0.05, 0.04) | 0.77 | +0.01 (−0.04, 0.06) | 0.73 |
SD12 | 0% (−8, 8) | 0.91 | +1% (−8, 8) | 0.95 |
Because most HRV indices were log-transformed prior to analysis, values represent the percent difference in each HRV index according to each one unit (one SD) of higher TFA consumption.
Normally distributed and were not log-transformed prior to analysis. Values represent absolute difference in each HRV index according to each one unit (one SD) of higher plasma phospholipid TFA.
Analyses adjusted for: age (years), gender (male/female), race (white/nonwhite), education (< high school, high school, > high school), income (≤/> $ 25,000/yr), clinical site (four categories), smoking (never/former/current), BMI (kg/m2), diabetes mellitus (yes/no), coronary heart disease (yes/no), hypertension (three categories), β-blocker use (yes/no), other anti-hypertensive medication use (yes/no), leisure-time physical activity (kcal/week), alcohol (drinks/week), and consumption of total energy (kcal/d), trans-16:1 fatty acids (mg/day), EPA and DHA (quintiles), fruits (quintiles), and vegetables (quintiles). All models also mutually adjusted for consumption of trans-18:2 and trans-18:1 to investigate their independent effects.
Because erratic (abnormal sinus) HRV is common in older adults and can bias certain HRV indices, rMSSD, LFnu, and HFnu were evaluated among individuals with lower erratic HRV (DFA>median; n =625), consistent with our prior methods for HRV analyses in this cohort.28
In sensitivity analyses, results for pNN50 were generally similar to those for rMSSD; and we found no significant associations of TFA with heart rate turbulence (HRT).
R-squared values are the following: 0.21 (24-hour HR); 0.19 (resting HR); 0.15 (SDNN); 0.15 (SDANN); 0.14 (SDNNindex); 0.10(rMSSD); 0.14 (TP); 0.15 (ULF); 0.17 (VLF); 0.17 (LF/HF ratio); 0.13 (LFnu); 0.16 (HFnu); 0.17 (DFA1); 0.14 (SD12). nu = normalized units